The next frontier to treat cancer: electricity
UC expert featured in Wall Street Journal article
The University of Cincinnati Cancer Center's Kyle Wang was featured in a Wall Street Journal article discussing research and advancements in using electricity as a treatment for cancer.
While pacemakers to keep heartbeats steady and electroconvulsive therapy to treat mental health disorders have been in use for decades, there is more of a focus on applying electricity to treat other diseases including cancer.
Wang, MD, Cancer Center physician researcher and associate professor in the Department of Radiation Oncology in UC's College of Medicine, studies the use of a device that delivers electricity through a cap worn on patient's heads to treat glioblastoma brain tumors. He is currently an investigator in a trial testing if wearing the device during initial treatment like chemotherapy or radiation will lead to better outcomes.
“Electricity, if it treats cancer, it should treat most kinds of cancer,” Wang told the Wall Street Journal. “The next 10 years are really going to be testing this.”
Read the Wall Street Journal article.
Read more about Wang's research.
Featured photo at top of patient with Optune device arrays being applied. Reproduced with permission from Novocure GmbH ©2021 Novocure GmbH – All rights reserved. Permission for global use was obtained from the patient.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.